← Back to Search

Behavioural Intervention

Treatment Arm for Cancer

N/A

Waitlist Available

Research Sponsored by University of California, Irvine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion; approximately 1.5 years

Awards & highlights

Study Summary

This trial aims to see if using electroacupuncture can help manage symptoms like pain, nausea, diarrhea, and insomnia in patients who have had a specific type of surgery and chemotherapy. The study will also

Who is the study for?

This trial is for patients who've had Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to treat cancer. It's designed to see if electroacupuncture can help manage symptoms like pain, nausea, vomiting, diarrhea, and insomnia post-surgery.Check my eligibility

What is being tested?

The study tests the use of electroacupuncture as a treatment for managing symptoms after specific cancer surgeries. The goal is to assess how well it works (effectiveness), how safe it is (safety), and whether patients are willing to stick with it (compliance).See study design

What are the potential side effects?

While not explicitly stated in the provided information, common side effects of electroacupuncture may include slight bleeding or bruising at needle sites, dizziness or fainting. Serious side effects are rare.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion; approximately 1.5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion; approximately 1.5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; approximately 1.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Number of Completed Electroacupuncture Sessions

Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Number of Patients Recruited

Feasibility in utilizing an EA for patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Patient Recruitment Rate

+3 more

Secondary outcome measures

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Symptoms - EORTC QLQ-C30

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Symptoms - FACT-Cog version 3

Efficacy of EA in managing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Symptoms - EORTC QLQ-C30

+1 more

Other outcome measures

Biomarkers - Plasma (pg/mL)

Biomarkers - Plasma BDNF (pg/ml)

Biomarkers - Plasma cytokines (IL-1β, IL-4, IL-6, IL-8, IL-10, TNF-alpha, pg/mL)

+9 more

Side effects data

From 2007 Phase 2 trial • 57 Patients • NCT00071110

32%

INCREASED DREAM ACTIVITY

29%

HEADACHE

25%

REDUCED DURATION OF SLEEP:

25%

NAUSEA / VOMITING

25%

ORGASMIC DYSFUNCTION

11%

DIMINISHED SEXUAL DESIRE

11%

INCREASED DURATION OF SLEEP:

11%

INCREASED TENDENCY TO SWEATING

11%

ORTHOSTATIC DIZZINESS

PHOTOSENSITIVITY

EMOTIONAL INDIFFERENCE

PALPITATIONS / TACHYCARDIA

RASH

DRY VAGINA

SLEEPINESS / SEDATION

ASTHENIA / LASSITUDE / INCREASED FATIGUABILITY

FAILING MEMORY

TENSION / INNER UNREST

DIARRHEA

PRURITUS

100%

80%

60%

40%

20%

Study treatment Arm

Electroacupuncture (EA)

Sham Acupuncture (SA)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Treatment ArmExperimental Treatment1 Intervention

Each participant will attend a total of 8 treatment visits (one visit per week), over the course of 8 weeks. Each EA session will be approximately 1 hour. Participants in the treatment arm will receive EA at 10 standardized acu-points that were chosen for their therapeutic effects.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor

544 Previous Clinical Trials

1,923,023 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"Information from clinicaltrials.gov indicates that the current trial is not actively seeking participants. Despite being posted on 5/15/2024 and last updated on 3/25/2024, there are no ongoing recruitment efforts for this study. Nevertheless, it's important to note that out of a pool of active trials, there are currently 626 others open for patient enrollment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Oliver Eng 2024. "Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06340906.

All > Hyperthermia